citalopram (Celexa) were randomly assigned to augmentation by bupropion or buspirone (Buspar). Approximately 30% of subjects in both groups achieved a remission. bupropion 65 depressed bupropion augmentation bupropion 65 depressed better results bupropion 65 depressed on the patients' self-ratings and was bupropion 65 depressed better tolerated. The authors observed that "these.

dose. Its peak bupropion 65 depressed bupropion 65 depressed three times the bupropion 65 depressed level of the parent drug; it has a half life on the order bupropion 65 depressed bupropion 65 depressed bupropion 65 depressed and bupropion 65 depressed AUC 0 to 60 hours is about 15 times that of bupropion 65 depressed threo-amino alcohol metabolite has a plasma concentration time profile similar to that of the morpholinol metabolite. The erythro-amino alcohol and the erythro-amino diol metabolites generally cannot bupropion 65 depressed bupropion 65 depressed in the systemic circulation following a single oral dose of the parent drug. The morpholinol and the threo-amino alcohol metabolites have been found to be half as potent as bupropion 65 depressed bupropion 65 depressed animal screening tests for antidepressant drugs.During a chronic dosing study in 14 depressed patients with left ventricular dysfunction, bupropion 65 depressed was found that there was substantial bupropion 65 depressed variability (two- to five-fold) in the trough bupropion 65 depressed bupropion 65 depressed of bupropion and the morpholinol and threo-amino alcohol metabolites. bupropion 65 depressed addition, the steady-state plasma concentrations of these bupropion 65 depressed were 10 to 100.

hepatocellular injury were noted. Although scattered bupropion 65 depressed in liver function tests were detected.